24117115|t|Tryptamine induces axonopathy and mitochondriopathy mimicking neurodegenerative diseases via tryptophanyl-tRNA deficiency.
24117115|a|Neurodegeneration is induced by tryptamine, a human diet constituent, which easily crosses the blood/brain barrier. Tryptamine neurotoxicity, caused by tryptophanyl-tRNA synthetase (TrpRS) inhibition and downregulation leads to tryptophanyl-tRNA deficiency and synthesis of aberrant proteins. We identified axonal defects in hippocampus of tryptamine- treated mice similar to those observed in human brain of patients with Alzheimer's disease, multiple sclerosis and epilepsy using anti-TrpRS site-directed antibodies. The axonal defects are characterized by swellings that accumulate abnormal amounts of helical filaments and amyloid. Tryptamine produced a decreased density of somatic mitochondria concomitant with neuronal loss in mouse hippocampus. In addition, tryptamine evoked accumulation and clustering of small mitochondria in mouse hippocampus causing axonal swellings. Similarly, mitochondrial fission, fusion and clustering were revealed in human neuronal cells after tryptamine administration. Moreover the tryptamine-induced mitochondrial neuropathology includes electron-dense deposits comprising helical fibrils, cristae disruption, cristolysis, mitochondrial swelling and mitochondria-derived vesicles. TrpRS+ helical filamentous tangles formed in both neuronal and kidney cells following tryptamine treatment suggest a tryptamine broad cytotoxic repertoire in damaging vital organs. Tryptamine elicited vesicularization of inner and outer mitochondrial membranes, axonal and cell membranes. Ultrastructurally, fragmentation of swollen degenerated mitochondria, small mitochondria clustering and neurofibrillary tangles are associated with axonal membrane protrusions attributed as neuritic swellings at a lower magnification. TrpRS+ axonal swellings associated with neuropathology of patients and tryptamine-treated human cells suggest that under toxic concentrations, tryptamine is implicated as a causative agent in neurodegeneration resembling that defining a number of human diseases. 
24117115	0	10	Tryptamine	Chemical	MESH:C030820
24117115	19	29	axonopathy	Disease	MESH:D016472
24117115	34	51	mitochondriopathy	Disease	
24117115	62	88	neurodegenerative diseases	Disease	MESH:D019636
24117115	93	121	tryptophanyl-tRNA deficiency	Disease	OMIM:615281
24117115	123	140	Neurodegeneration	Disease	MESH:D019636
24117115	155	165	tryptamine	Chemical	MESH:C030820
24117115	169	174	human	Species	9606
24117115	239	263	Tryptamine neurotoxicity	Disease	MESH:D020258
24117115	275	303	tryptophanyl-tRNA synthetase	Gene	7453
24117115	305	310	TrpRS	Gene	7453
24117115	351	379	tryptophanyl-tRNA deficiency	Disease	OMIM:615281
24117115	430	444	axonal defects	Disease	MESH:D020269
24117115	463	473	tryptamine	Chemical	MESH:C030820
24117115	483	487	mice	Species	10090
24117115	517	522	human	Species	9606
24117115	532	540	patients	Species	9606
24117115	546	565	Alzheimer's disease	Disease	MESH:D000544
24117115	567	585	multiple sclerosis	Disease	MESH:D009103
24117115	590	598	epilepsy	Disease	MESH:D004827
24117115	610	615	TrpRS	Gene	7453
24117115	646	660	axonal defects	Disease	MESH:D020269
24117115	759	769	Tryptamine	Chemical	MESH:C030820
24117115	840	853	neuronal loss	Disease	MESH:D009410
24117115	857	862	mouse	Species	10090
24117115	889	899	tryptamine	Chemical	MESH:C030820
24117115	960	965	mouse	Species	10090
24117115	986	1002	axonal swellings	Disease	MESH:D004487
24117115	1077	1082	human	Species	9606
24117115	1104	1114	tryptamine	Chemical	MESH:C030820
24117115	1144	1154	tryptamine	Chemical	MESH:C030820
24117115	1163	1191	mitochondrial neuropathology	Disease	MESH:D028361
24117115	1286	1308	mitochondrial swelling	Disease	MESH:D028361
24117115	1344	1349	TrpRS	Gene	7453
24117115	1430	1440	tryptamine	Chemical	MESH:C030820
24117115	1461	1471	tryptamine	Chemical	MESH:C030820
24117115	1525	1535	Tryptamine	Chemical	MESH:C030820
24117115	1737	1760	neurofibrillary tangles	Disease	MESH:D055956
24117115	1823	1831	neuritic	Disease	MESH:D058225
24117115	1868	1873	TrpRS	Gene	7453
24117115	1875	1891	axonal swellings	Disease	MESH:D004487
24117115	1908	1922	neuropathology	Disease	MESH:D009422
24117115	1926	1934	patients	Species	9606
24117115	1939	1949	tryptamine	Chemical	MESH:C030820
24117115	1958	1963	human	Species	9606
24117115	2011	2021	tryptamine	Chemical	MESH:C030820
24117115	2060	2077	neurodegeneration	Disease	MESH:D019636
24117115	2115	2120	human	Species	9606
24117115	Association	MESH:C030820	MESH:D000544
24117115	Positive_Correlation	MESH:C030820	MESH:D009410
24117115	Association	MESH:C030820	MESH:D004827
24117115	Association	MESH:C030820	7453
24117115	Positive_Correlation	MESH:C030820	MESH:D019636
24117115	Positive_Correlation	MESH:C030820	MESH:D055956
24117115	Association	MESH:C030820	MESH:D009103
24117115	Association	MESH:D009422	7453
24117115	Positive_Correlation	MESH:C030820	MESH:D020269
24117115	Positive_Correlation	MESH:C030820	OMIM:615281
24117115	Positive_Correlation	MESH:C030820	MESH:D004487
24117115	Negative_Correlation	MESH:D020258	7453
24117115	Positive_Correlation	OMIM:615281	7453
24117115	Association	MESH:D020269	7453
24117115	Positive_Correlation	MESH:C030820	MESH:D028361
24117115	Positive_Correlation	MESH:C030820	MESH:D016472

